학술논문
1162P Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP): First real-world evidence of NSCLC stage II and III in Germany - AIO-TRK-0315
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S935-S936
Subject
Language
ISSN
0923-7534